The role of TGF-β and epithelial-to mesenchymal transition in diabetic nephropathy

Cytokine and Growth Factor Reviews

Volumn 22, Issue 3, 2011, Pages 131-139

  Hills, Claire E ^a   Squires, Paul E ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

Diabetic nephropathy; Epithelial to mesenchymal transition; Renal fibrosis; Transforming growth factor beta

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; C PEPTIDE; CALVASCULIN; MICRORNA; MICRORNA 192; OSTEOGENIC PROTEIN 1; PROTEIN SMURF2; SCATTER FACTOR; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; SMAD PROTEIN; SMAD UBIQUITINATION REGULATORY FACTOR 2; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD7 PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

AUTOPHOSPHORYLATION; CELL ADHESION; CELL PROLIFERATION; DIABETIC NEPHROPATHY; EPITHELIAL MESENCHYMAL TRANSITION; GENE; GLOMERULOSCLEROSIS; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INTRACELLULAR SIGNALING; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; MYOFIBROBLAST; NEPHRON; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SHORT SURVEY; SNON GENE; TRANSFORMING GROWTH FACTOR BETA1 GENE; TUBULOINTERSTITIAL FIBROSIS;

ANIMALS; CELL DIFFERENTIATION; DIABETIC NEPHROPATHIES; EPITHELIAL-MESENCHYMAL TRANSITION; FIBROBLASTS; FIBROSIS; HUMANS; KIDNEY TUBULES; MYOBLASTS; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 80052317444     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2011.06.002     Document Type: Short Survey

References (125)

1. US Renal Data System (USRDS). Annual data report: atlas of end-stage renal disease in the United States. Bethesda, MD: National Institute of Health, National Institute of Diabetes and Digestive and Kidney Disease; 2003.
2. Wolfe R.A., Port F.K., Webb R.L., Bloembergen W.E., Hirth R., Young E.W., et al. Introduction to the excerpts from the United States Renal Data System 1999 Annual Data Report. Am J Kidney Dis 1999, 34:S1-S3.
3. Soldatos G., Cooper M.E. DN: Important pathophysiologic mechanisms. Diabetes Res Clin Pract 2008, 82:S75-S79.
4. Mauer S.M., Steffes M.W., Ellis E.N., Sutherland D.E., Brown D.M., Goetz F.C. Structural functional relationships in DN. J Clin Invest 1984, 74:1143-1155.
5. Steffes M.W., Osterby R., Chavers B., Mauer S.M. Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 1989, 38:1077-1081.
6. Mason R.M., Wahab N.A. Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol 2003, 14:1358-1373.
7. Nangaku M. Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure. Intern Med 2004, 43:9-17.
8. Wolf G. New insights into the pathophysiology of diabetic nephropathy: from hemodynamics to molecular pathology. Eur J Clin Invest 2004, 34:785-796.
9. Hills C.E., Squires P.E. TGF-beta1-induced epithelial-to-mesenchymal transition and therapeutic intervention in diabetic nephropathy. Am J Nephrol 2010, 31:68-74.
10. Iwano M., Plieth D., Danoff T.M., Xue C., Okada H., Neilson E.G. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002, 110:341-350.
11. Ju W., Ogawa A., Heyer J., Nierhof D., Yu L., Kucherlapati R., et al. Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation. Mol Cell Biol 2006, 26:654-667.
12. Thiery J.P. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 2003, 15:740-746.
13. Rastaldi M.P., Ferrario F., Giardino L., Dell'Antonio G., Grillo C., Grillo P., et al. Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies. Kidney Int 2002, 62:137-146.
14. Zeisberg M., Kalluri R. The role of epithelial-to-mesenchymal transition in renal fibrosis. J Mol Med 2004, 82:175-181.
15. Kanwar Y.S., Wada J., Sun L., Xie P., Wallner E.I., Chen S., et al. Diabetic nephropathy: mechanisms of renal disease progression. Exp Biol Med 2008, 233:4-11.
16. Sharma K., Ziyadeh F. Hyperglycaemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator. Diabetes 1996, 44:1139-1146.
17. Border WA, Noble NA, Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1194;10:1286-92.
18. Bieke F., Schrijvers, An S., De Vriese, Allan Flyvbjerg From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines. Endocrine Rev 2004, 25:971-1010.
19. Dan D.C., Hoffman B.B., Hong S.W. Therapy with antisense TGF-β1 oligodeoxynucleotides reduces kidney weight and matrix mRNAs in diabetic mice. Am J Physiol Renal Physiol 2000, 278:F628-F634.
20. Ziyadeh F.N. The extracellular matrix in DN. Am J Kidney Dis 1992, 22:36-744.
21. Chen S., Hong S.W., Iglesias-de la Cruz M.C., Isono M., Casaretto A., Ziyadeh F.N. The key role of the transforming growth factor-beta system in the pathogenesis of diabetic nephropathy. Ren Fail 2001, 23:471-481.
22. Sharma K., Jin Y., Guo J., Ziyadeh F.N. Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 1996, 45:522-530.
23. Border W.A., Yamamoto T., Noble N.A. Transforming growth factor beta in diabetic nephropathy. Diabetes Metab Rev 1996, 12:309-339.
24. Ziyadeh F.N., Sharma K., Ericksen M., Wolf G. Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta. J Clin Invest 1994, 93:536-542.
25. Ziyadeh F.N., Wolf G. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy. Curr Diabetes Rev 2008, 4:39-45.
26. Bae J.S., Kim I.S., Rezaie A.R. Thrombin down-regulates the TGF-beta-mediated synthesis of collagen and fibronectin by human proximal tubule epithelial cells through the EPCR-dependent activation of PAR-1. J Cell Physiol 2010, 225:233-239.
27. Reiniger N., Lau K., McCalla D., Eby B., Cheng B., Lu Y., et al. Deletion of the receptor for advanced glycation end products reduces glomerulosclerosis and preserves renal function in the diabetic OVE26 mouse. Diabetes 2010, 59:2043-2054.
28. Slattery C., Ryan M.P., McMorrow T. Protein kinase C beta overexpression induces fibrotic effects in human proximal tubular epithelial cells. Int J Biochem Cell Biol 2008, 40:2218-2229.
29. Iwano M., Kubo A., Nishino T., Sato H., Nishioka H., Akai Y., et al. Quantification of glomerular TGF-beta 1 mRNA in patients with diabetes mellitus. Kidney Int 1996, 49:1120-1126.
30. Sharma K., Ziyadeh F.N., Alzahabi B., McGowan T.A., Kapoor S., Kurnik B.R., et al. Increased renal production of transforming growth factor-beta1 in patients with type II diabetes. Diabetes 1997, 46:854-859.
31. Wrighton K.H., Lin X., Feng X.H. Phospho-control of TGF-beta superfamily signaling. Cell Res 2009, 19:8-20.
32. Schmierer B., Hill C.S. TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility. Nat Rev Mol Cell Biol 2007, 8:970-982.
33. Bottinger E.P., Bitzer M. TGF-beta signaling in renal disease. J Am Soc Nephrol 2002, 13:2600-2610.
34. Pelton R.W., Saxena B., Jones M., Moses H.L., Gold L.I. Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J Cell Biol 1991, 115:1091-1105.
35. Massagué J., Chen Y.G. Controlling TGF-beta signaling. Genes Dev 2000, 14:627-644.
36. Kristine C.Nyhan, Faherty Noel, Murray Gregg, Cooey Laurence Berubé, Godson Catherine, Crean John K., et al. Jagged/Notch signalling is required for a subset of TGFβ1 responses in human kidney epithelial cells. Biochim Biophys Acta 2010, 1803:1386-1395.
37. Gentry L.E., Lioubin M.N., Purchio A.F., Marquardt H. Molecular events in the processing of recombinant type 1 pre-pro-transforming growth factor beta to the mature polypeptide. Mol Cell Biol 1988, 8:4162-4168.
38. Ribeiro S.M., Poczatek M., Schultz-Cherry S., Villain M., Murphy-Ullrich J.E. The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta. J Biol Chem 1999, 274:13586-13593.
39. Dennler S., Itoh S., Vivien D., Dijke P., Huet S., Gauthier J. Direct binding of smad3 and smad4 to critical TGF-β inducible elements in the promoter of the human plasminogen activator inhibitor-type 1 gene. EMBO J 1998, 17:3091-3100.
40. Itoh S., Thorikay M., Kowanetz M., Moustakas A., Itoh F., Heldin C.H., et al. Elucidation of Smad requirement in transforming growth factor-beta type I receptor-induced responses. J Biol Chem 2003, 278:3751-3761.
41. Kim S.J., Angel P., Lafyatis R., Hattori K., Kim K.Y., Sporn M.B., et al. Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex. Mol Cell Biol 1990, 12:1492-1497.
42. Van Obberghen-Schilling E., Roche N.S., Flanders K.C., Sporn M.B., Roberts A.B. Transforming growth factor β1 positively regulates its own expression in normal and transformed cells. J Biol Chem 1988, 263:7741-7746.
43. Zhang M., Fraser D., Phillips A. ERK, p38, and Smad signaling pathways differentially regulate transforming growth factor-beta1 autoinduction in proximal tubular epithelial cells. Am J Pathol 2006, 169:1282-1293.
44. Flanders K.C., Holder M.G., Winokur T.S. Autoinduction of mRNA and protein expression for transforming growth factor-beta S in cultured cardiac cells. J Mol Cell Cardiol 1995, 27:805-812.
45. Sato M., Muragaki Y., Saika S., Roberts A.B., Ooshima A. Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest 2003, 112:1486-1494.
46. Piek E., Ju W.J., Heyer J., Escalante-Alcalde D., Stewart C.L., Weinstein M., et al. Functional characterisation of transforming growth factor β signaling in Smad2- and Smad3 deficient fibroblasts. J Biol Chem 2001, 276:19945-19953.
47. Wang W., Koka V., Lan H.Y. Transforming growth factor-beta and Smad signalling in kidney diseases. Nephrology 2005, 10:48-56.
48. Yang J., Zhang X., Li Y., Liu Y. Downregulation of Smad transcriptional corepressors SnoN and Ski in the fibrotic kidney: an amplification mechanism for TGF-beta1 signaling. J Am Soc Nephrol 2003, 14:3167-3177.
49. Yeh Y.C., Wei W.C., Wang Y.K., Lin S.C., Sung J.M., Tang M.J. Transforming growth factor-{beta}1 induces Smad3-dependent {beta}1 integrin gene expression in epithelial-to-mesenchymal transition during chronic tubulointerstitial fibrosis. Am J Pathol 2010, 177:1743-1754.
50. Brown K.A., Pietenpol J.A., Moses H.L. A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling. J Cell Biochem 2007, 101:9-33.
51. Valcourt U., Kowanetz M., Niimi H., Heldin C.H., Moustakas A. TGF-beta and the Smad signaling pathway support transcriptomic programming during epithelial-mesenchymal cell transition. Mol Biol Cell 2005, 16:1987-2002.
52. Luo K. Ski and SnoN: negative regulators of TGF-beta signaling. Curr Opin Genet Dev 2004, 14:65-70.
53. Yang F., Huang X.R., Chung A.C., Hou C.C., Lai K.N., Lan H.Y. Essential role for Smad3 in angiotensin II-induced tubular epithelial-mesenchymal transition. J Pathol 2010, 221:390-401.
54. Tan R., Zhang J., Tan X., Zhang X., Yang J., Liu Y. Downregulation of SnoN expression in obstructive nephropathy is mediated by an enhanced ubiquitin-dependent degradation. J Am Soc Nephrol 2006, 17:2781-2791.
55. Lan H.Y. Smad7 as a therapeutic agent for chronic kidney diseases. Front Biosci 2008, 13:4984-4992.
56. Li J.H., Zhu H.J., Huang X.R., Lai K.N., Johnson R.J., Lan H.Y. Smad7 inhibits fibrotic effect of TGF-Beta on renal tubular epithelial cells by blocking Smad2 activation. J Am Soc Nephrol 2002, 13:1464-1472.
57. Nakao A., Okumura K., Ogawa H. Smad7: a new key player in TGF-beta-associated disease. Trends Mol Med 2002, 8:361-363.
58. Park S.H. Fine tuning and cross-talking of TGF-beta signal by inhibitory Smads. J Biochem Mol Biol 2005, 38:9-16.
59. Yan X., Liu Z., Chen Y. Regulation of TGF-beta signaling by Smad7. Acta Biochim Biophys Sin (Shanghai) 2009, 41:263-272.
60. Masszi A., Fan L., Rosivall L., McCulloch C.A., Rotstein O.D., Mucsi I., Kapus A. Integrity of cell-cell contacts is a critical regulator of TGF-beta 1-induced epithelial-to-myofibroblast transition: role for beta-catenin. Am J Pathol. 2004, 165:1955-1967.
61. Tan R., He W., Lin X., Kiss L.P., Liu Y. Smad ubiquitination regulatory factor-2 in the fibrotic kidney: regulation, target specificity, and functional implication. Am J Physiol Renal Physiol 2008, 294:F1076-F1083.
62. Fukasawa H., Yamamoto T., Togawa A., Ohashi N., Fujigaki Y., Oda T., et al. Ubiquitin-dependent degradation of SnoN and Ski is increased in renal fibrosis induced by obstructive injury. Kidney Int 2006, 69:1733-1740.
63. Kalluri R., Weinberg R.A. The basics of epithelial-mesenchymal transition. J Clin Invest 2009, 119:1420-1428.
64. Kalluri R. EMT: when epithelial cells decide to become mesenchymal-like cells. J Clin Invest 2009, 119:1417-1419.
65. Zheng G., Lyons J.G., Tan T.K., Wang Y., Hsu T.T., Min D., et al. Disruption of E-cadherin by matrix metalloproteinase directly mediates epithelial-mesenchymal transition downstream of transforming growth factor-beta1 in renal tubular epithelial cells. Am J Pathol 2009, 175:580-591.
66. Nawshad A., Lagamba D., Polad A., Hay E.D. Transforming growth factor-beta signaling during epithelial-mesenchymal transformation: implications for embryogenesis and tumor metastasis. Cells Tissues Organs 2005, 179:11-23.
67. Zavadil J., Böttinger E.P. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 2005, 24:5764-5774.
68. Lee J.M., Dedhar S., Kalluri R., Thompson E.W. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 2006, 172:973-981.
69. Okada H., Ban S., Nagao S., Takahashi H., Suzuki H., Neilson E.G. Progressive renal fibrosis in murine polycystic kidney disease: an immunohistochemical observation. Kidney Int 2000, 58:587-597.
70. Galichon P., Hertig A. Epithelial to mesenchymal transition as a biomarker in renal fibrosis: are we ready for the bedside?. Fibrogenesis Tissue Rep. 2011, 6(4):11.
71. Badid C., Desmouliere A., Babici D., Hadj-Aissa A., McGregor B., Lefrancois N., et al. Interstitial expression of alpha-SMA: an early marker of chronic renal allograft dysfunction. Nephrol Dial Transplant 2002, 17:1993-1998.
72. Vongwiwatana A., Tasanarong A., Rayner D.C., Melk A., Halloran P.F. Epithelial to mesenchymal transition during late deterioration of human kidney transplants: the role of tubular cells in fibrogenesis. Am J Transplant 2005, 5:1367-1374.
73. Kida Y., Duffield J.S. Frontiers in research: chronic kidney diseases: the pivotal role of pericytes in kidney fibrosis. Clin Exp Pharmacol Physiol 2011, 38:417-423.
74. Schrimpf C., Duffield J.S. Mechanisms of fibrosis: the role of the pericyte. Curr Opin Nephrol Hypertens 2011, 20:297-305.
75. Quaggin S.E., Kapus A. Scar wars: mapping the fate of epithelial-mesenchymal-myofibroblast transition. Kidney Int 2011, 80:41-50.
76. Strutz F., Zeisberg M. Renal fibroblasts and myofibroblasts in chronic kidney disease. J Am Soc Nephrol 2006, 17:2992-2998.
77. Lin S.L., Kisseleva T., Brenner D.A., Duffield J.S. Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am J Pathol 2008, 173:1617-1627.
78. Humphreys B.D., Lin S.L., Kobayashi A., Hudson T.E., Nowlin B.T., Bonventre J.V., et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 2010, 176:85-97.
79. Keeley E.C., Mehrad B., Strieter R.M. Fibrocytes: bringing new insights into mechanisms of inflammation and fibrosis. Int J Biochem Cell Biol 2010, 42:535-542.
80. Zeisberg M., Duffield J.S. Resolved: EMT produces fibroblasts in the kidney. J Am Soc Nephrol 2010, 21:1247-1253.
81. Kim K.K., Kugler M.C., Wolters P.J., Robillard L., Galvez M.G., Brumwell A.N., et al. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci USA 2006, 103:13180-13185.
82. Zeisberg M., Yang C., Martino M., Duncan M.B., Rieder F., Tanjore H., et al. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 2007, 282:23337-23347.
83. Flier S.N., Tanjore H., Kokkotou E.G., Sugimoto H., Zeisberg M., Kalluri R.J. Identification of epithelial to mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis. Biol Chem 2010, 285:20202-20212.
84. Strutz F., Okada H., Lo C.W., Danoff T., Carone R.L., Tomaszewski J.E., et al. Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 1995, 130:393-405.
85. Ng Y.Y., Huang T.P., Yang W.C., Chen Z.P., Yang A.H., Mu W., et al. Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int 1998, 54:864-876.
86. Burns W.C., Twigg S.M., Forbes J.M., Pete J., Tikellis C., Thallas-Bonke V., et al. Connective tissue growth factor plays an important role in advanced glycation end product-induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease. J Am Soc Nephrol 2006, 7:2484-2494.
87. Li Y., Yang J., Dai C., Wu C., Liu Y. Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. J Clin Invest 2003, 112:503-516.
88. Yamaguchi Y., Iwano M., Suzuki D., Nakatani K., Kimura K., Harada K., et al. Epithelial-mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy. Am J Kidney Dis 2009, 54:653-664.
89. Holian J., Qi W., Kelly D.J., Zhang Y., Mreich E., Pollock C.A., et al. Role of Kruppel-like factor 6 in transforming growth factor-beta1-induced epithelial-mesenchymal transition of proximal tubule cells. Am J Physiol Renal Physiol 2008, 295:F1388-F1396.
90. Martinez J., Tuschl T. RISC is a 5' phosphomonoester-producing RNA endonuclease. Genes Dev 2004, 18:975-980.
91. Krupa A., Jenkins R., Luo D.D., Lewis A., Phillips A., Fraser D. Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy. J Am Soc Nephrol 2010, 21:438-447.
92. Wang B., Koh P., Winbanks C., Coughlan M.T., McClelland A., Watson A., et al. miR-200a Prevents renal fibrogenesis through repression of TGF-β2 expression. Diabetes 2011, 60:280-287.
93. Butt M.J., Tarantal A.F., Jimenez D.F., Matsell D.G. Collecting duct epithelial-mesenchymal transition in fetal urinary tract obstruction. Kidney Int 2007, 72:936-944.
94. Ivanova L., Butt M.J., Matsell D.G. Mesenchymal transition in kidney collecting duct epithelial cells. Am J Physiol Renal Physiol 2008, 294:F1238-F1248.
95. Yang J., Liu Y. Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J Am Soc Nephrol 2002, 13:96-107.
96. Aldehni F., Spitzner M., Martins J.R., Barro-Soria R., Schreiber R., Kunzelmann K. Bestrophin 1 promotes epithelial-to-mesenchymal transition of renal collecting duct cells. J Am Soc Nephrol 2009, 20:1556-1564.
97. Gewin L., Bulus N., Mernaugh G., Moeckel G., Harris R.C., Moses H.L., et al. TGF-beta receptor deletion in the renal collecting system exacerbates fibrosis. J Am Soc Nephrol 2010, 1:1334-1343.
98. Hills C.E., Squires P.E., Bland R. Serum and glucocorticoid regulated kinase and disturbed renal sodium transport in diabetes. J Endocrinol 2008, 199:343-349.
99. Loffing J., Flores S.Y., Staub O. Sgk kinases and their role in epithelial transport. Annu Rev Physiol 2006, 68:461-490.
100. Hills C.E., Bland R., Bennett J., Ronco P.M., Squires P.E. High glucose up-regulates ENaC and SGK1 expression in HCD-cells. Cell Physiol Biochem 2006, 18:337-346.
101. Kumar J.M., Brooks D.P., Olson B.A., Laping N.J. SGK a putative serine/threonine kinase is differentially expressed in the kidney of diabetic mice and humans. J Am Soc Nephrol 1999, 10:2488-2494.
102. Wärntges S., Klingel K., Weigert C., Fillon S., Buck M., Schleicher E., et al. Excessive transcription of the human serum and glucocorticoid dependent kinase hSGK1 in lung fibrosis. Cell Physiol Biochem 2002, 12:135-142.
103. De Albuquerque D.A., Saxena V., Adams D.E., Boivin G.P., Brunner H.I., Witte D.P., et al. An ACE inhibitor reduces Th2 cytokines and TGF-beta1 and TGF-beta2 isoforms in murine lupus nephritis. Kidney Int 2004, 65:846-859.
104. Hill C., Flyvbjerg A., Grønbaek H., Petrik J., Hill D.J., Thomas C.R., et al. The renal expression of transforming growth factor-beta isoforms and their receptors in acute and chronic experimental diabetes in rats. Endocrinology 2000, 141:1196-1208.
105. Hill C., Flyvbjerg A., Rar R., Bak M., Logan A. Transforming growth factor-beta2 antibody attenuates fibrosis in the experimental diabetic rat kidney. J Endocrinol 2001, 170:647-651.
106. Coker R.K., Laurent G.J., Shahzeidi S., Lympany P.A., du Bois R.M., Jeffery P.K., et al. Transforming growth factors-beta 1, -beta 2, and -beta 3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis. Am J Pathol 1997, 150:981-991.
107. Ziyadeh F.N., Hoffman B.B., Han D.C., Iglesias-de la Cruz M.C., Hong S.W., Isono M., et al. Long term prevention of renal insufficiency. Excess matrix gene expression and glomerular mesangial matrix expression by treatment with monoclonal anti-TGFβ antibody in db/db diabetic mice. Proc Natl Acad Sci USA 2000, 97:8015-8020.
108. Dolan V., Murphy M., Sadlier D., Lappin D., Doran P., Godson C., et al. Expression of gremlin, a bone morphogenetic protein antagonist, in human DN. Am J Kidney Dis 2005, 45:1034-1039.
109. Wang S.N., Lapage J., Hirschberg R. Loss of tubular bone morphogenetic protein-7 in DN. J Am Soc Nephrol 2001, 2:2392-2399.
110. Morrissey J., Hruska K., Guo G., Wang S., Chen Q., Klahr S. Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function. J Am Soc Nephrol 2002, 3:S14-S21.
111. Mitu G., Hirschberg R. Bone morphogenetic protein-7 (BMP7) in chronic kidney disease. Front Biosci 2008, 13:4726-4739.
112. Zeisberg M., Shah A.A., Kalluri R. Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney. J Biol Chem 2005, 280:8094-8100.
113. Dudas P.L., Argentieri R.L., Farrell F.X. BMP-7 fails to attenuate TGF-beta1-induced epithelial-to-mesenchymal transition in human proximal tubule epithelial cells. Nephrol Dial Transplant 2009, 24:1406-1416.
114. Yang J., Dai C., Liu Y. Systemic administration of naked plasmid encoding hepatocyte growth factor ameliorates chronic renal fibrosis in mice. Gene Ther 2001, 8:1470-1479.
115. Hills C.E., Willars G.B., Brunskill N.J. Proinsulin C-peptide antagonizes the profibrotic effects of TGF-beta1 via up-regulation of retinoic acid and HGF-related signaling pathways. Mol Endocrinol 2010, 24:822-831.
116. Yang J., Dai C., Liu Y. A novel mechanisms by which hepatocyte growth factor blocks tubular epithelilal to mesenchymal transition. J Am Soc Nephrol 2005, 16:68-78.
117. Wen X., Li Y., Hu K., Dai C., Liu Y. Hepatocyte growth factor receptor signaling mediates the anti-fibrotic action of 9-cis-retinoic acid in glomerular mesangial cells. Am J Pathol 2005, 167:947-957.
118. Masaki T., Doi S., Arakawa T., Yokoyama Y., Doi T., Kohno N., et al. PPAR-gamma agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-beta. Lab Invest 2009, 89:47-58.
119. Tan X., Li Y., Liu Y. Therapeutic role and potential mechanisms of active Vitamin D in renal interstitial fibrosis. J Steroid Biochem Mol Biol 2007, 103:491-496.
120. Junwei Yang, Youhua Liu. Delayed administration of hepatocyte growth factor reduces renal fibrosis in obstructive nephropathy. Am J Physiol Renal Physiol 2003, 284:F349-F357.
121. Hills C.E., Al-Rasheed N., Al-Rasheed N., Willars G.B., Brunskill N.J. C-peptide reverses TGF-beta-1 induced changes in renal proximal tubular cells: implications for treatment of DN. Am J Physiol 2009, 296:F614-F621.
122. Hills C.E., Brunskill N.J. Cellular and physiological effects of C-peptide. Clin Sci 2009, 116:565-567.
123. Hills C.E., Brunskill N.J., Squires P.E. C-peptide as a therapeutic tool in diabetic nephropathy. Am J Nephrol 2010, 31:389-397.
124. Kato M., Zhang J., Wang M., Lanting L., Yuan H., Rossi J.J., et al. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci USA 2007, 104:3432-3437.
125. Gregory P.A., Bert A.G., Paterson E.L., Barry S.C., Tsykin A., Farshid G., et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008, 10:593-601.